Navigation Links
Wright Therapy Products, Inc. Closes $3 million Financing Round
Date:12/7/2012

PITTSBURGH, Dec. 7, 2012 /PRNewswire/ -- Wright Therapy Products, Inc., a market leader in providing home-based solutions for patients suffering from lymphedema and venous insufficiency, announced today that they successfully closed a $3 million Series B financing round.  The capital raise was primarily subscribed by high-net-worth angel investors through Eagle Ventures, based in Shadyside, PA.

"We are very excited to complete the B round," said Michael Hinson, President and CEO of Wright Therapy.  "This funding will allow us to continue expanding our solution across the entire U.S.  Additionally, it will allow us to complete exciting new product development projects that we believe will lead to a significant competitive advantage in the marketplace by providing a unique treatment method for patients suffering from these life-altering diseases."

Jim Liken, Chairman of Wright's Board of Directors commented, "As a whole, our investors are very aware of the changing healthcare landscape and the need to provide cost-effective means to care for the patient.  I believe that is what attracted the B round investors to Wright Therapy.  Our ComplyCare™ solution is a disease management program focused on providing the most effective and compliant treatment for the patient which leads to the best clinical outcome."

About Wright Therapy Products, Inc.
Wright Therapy Products, Inc., based in Oakdale, Pennsylvania is a Joint Commission accredited medical device company that manufactures and sells pneumatic compression devices targeted for the home-based treatment of lymphedema and chronic venous insufficiency.  The devices have received 510(k) Clearance from the U.S. FDA to treat these diseases.  Our disease management program, ComplyCare™, is a comprehensive patient compliance program that helps to ensure the best clinical outcome for the patient while reducing the overall cost-of-care.  Our founder invented the world's first sequential gradient pump to treat a family member suffering from lymphedema and we continue to lead through innovation with a goal of providing the best treatment solution for patients afflicted with lymphedema or chronic venous insufficiency. 


'/>"/>
SOURCE Wright Therapy Products, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Omeros Responds to Misleading Announcement by Davis Wright Tremaine Concerning Settlement with Former Chief Financial Officer
2. Althea Technologies Appoints Dr. Kristin DeFife, Director, Biologics Manufacturing And Jack Wright, VP, Sales and Marketing
3. Global Market for Radiation Therapy Equipment to Reach $6.8 Billion by 2018
4. Quebec Clinic Launches Canadian Use of Elektas Agility Beam-Shaping Innovation for Radiation Therapy of Cancer
5. ObeTherapy Announces the Publication of Results Obtained with one of its Lead Compounds on a New Target for the Treatment of Obesity and Type II Diabetes
6. Actinium Pharmaceuticals Sponsors Webinar on Clinical Use of Alpha Immunotherapy
7. Avaxia Biologics Receives IND Clearance from FDA to Initiate Clinical Program to Evaluate AVX-470 as Therapy for Ulcerative Colitis
8. Varian Medical Systems to Showcase Advanced Technologies for Treating Cancer with Image-Guided Radiotherapy and Radiosurgery at JASTRO Meeting in Tokyo, Japan
9. Insulin Administration and Nutritional Therapy Requires Standardized Coordination, Says ECRI Institute PSO
10. Dynamic Healthcare Services Acquires HomeTown Oxygen, Pittsburgh, LLC, a Provider of Medical Equipment and Respiratory Therapy Products and Services based in Monroeville, PA
11. National Patient Advocate Foundation Urges Ohio Legislature to Support Oral Chemotherapy Legislation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/28/2017)... CHICAGO , Sept. 28, 2017 Hill-Rom ... quarter 2017 earnings conference call and webcast on Friday, ... 8:00 a.m. (EDT) and ending at approximately 8:30 a.m. ... to discussing the company,s 2017 financial performance and guidance ... growth opportunities, initiatives to enhance operational performance, and long-range ...
(Date:9/27/2017)... MIAMI , Sept. 27, 2017  Commended for their ... recent notable awards. Ranked as number one in the South ... ninth time in Inc. 5000 yearly list, the national specialty ... CEO, Armando Bardisa will soon be honored by ... Set to receive his award ...
(Date:9/25/2017)... Sept. 25, 2017   Montrium , an ... solutions, today—from the IQPC Trial Master Files & ... NL)—announced that EastHORN Clinical Services has selected ... and TMF management. EastHORN, a leading European contract ... to increase transparency to enable greater collaboration with ...
Breaking Medicine Technology:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... “America On ... Christian identity. “America On The Brink” is the creation of published author, William ... several great-grandchildren. As a WWII veteran, he spent thirty years in the Navy. ...
(Date:10/12/2017)... CA (PRWEB) , ... October 12, 2017 , ... ... Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent technology. ... a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... to meet the demand of today’s consumer and regulatory authorities worldwide. From Children’s ... experts and tested to meet the highest standard. , These products are ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... The American ... Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium ... 8. , In honor of Morris F. Collen, a pioneer in the field of ...
(Date:10/12/2017)... ... 12, 2017 , ... Information about the technology: , Otomagnetics ... enable prevention of a major side effect of chemotherapy in children. Cisplatin and ... For cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. ...
Breaking Medicine News(10 mins):